News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Backs Medivo in $15 Million in Series B Round



6/24/2013 8:20:16 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medivo drums up $15 million in a Series B round led by Merck's Global Health Innovation fund. Merck (NYSE:MRK) led a $15 million Series B round for Medivo and its health data analytics platform. The round was also backed by repeat investors Safeguard Scientifics (NYSE:SFE) and MentorTech Ventures. Medivo has raised a total of $22 million to support its module for health analytics, which the company touts as HIPAA-compliant and user-friendly for physicians and patients.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at News Release
Read at Dow Jones


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES